Unleashing the Potential of Pharmacogenomics in Precision Medicine

Jun 27, 2025

10 likes | 94 Views

Explore the groundbreaking research and advancements in pharmacogenomics to unlock the potential for personalized medicine. This journal article delves into the intricate relationship between genetics and drug response, paving the way for more effective and tailored treatment strategies. Discover the latest findings and future prospects in this transformative field.

Share Presentation

Embed Code

aidan-ford

Download Presentation

Unleashing the Potential of Pharmacogenomics in Precision Medicine

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Figure 1 The Pharmacogenomics Journal (2014) 14, 182-191; doi:10.1038/tpj.2013.16

Cancer Pharmacogenomics From Bench to Bedside

Pharmacogenomics. The study of the role of inheritance in individual variation in drug response phenotypes.A major component of

533 views • 18 slides

V8 Pharmacogenomics

V8 Pharmacogenomics. Test 2 Review of lecture V7 + paper 6 . Pharmacogenomics.

418 views • 17 slides

Fuentes QE et al . Platelets, 2013;24:255-62.

Pharmacogenomics of cardiovascular drugs – Th e Example of Thienopyridines Prof . Gerard SIEST IFCC Worldlab 2014 Istanbul, June 23, 2014 Biomarkers and Personalized Pharmacotherapy Session.

871 views • 74 slides

Journal August 19, 2013

Journal August 19, 2013. What would happen if children ruled the world?. August 20, 2013. Library Orientation Book Checkout . Journal August 21, 2013. What is your favorite book and why?. Journal August 22, 2013.

228 views • 5 slides

Chapter 7: Pharmacogenomics

Chapter 7: Pharmacogenomics. Konrad J. Karczewski , Roxana Daneshjou , Russ B. Altman. Presented by: K M Sabidur Rahman Date: Mar 18, 2014. What we will learn?. Interactions between drugs (small molecules) and genes (proteins) Methods for pharmacogenomic discovery

1.14k views • 65 slides

World History Journal

World History Journal. 5 th Six Weeks. Today’s Lesson February 24-25, 2014. Journal Prompt: Enlightenment; Music Notes Quiz: Scientific Revolution & Enlightenment Chapter 23:3 The Spread of Enlightenment Ideas. Introduce Project: Revolutions. Journal Warm-up for February 24-25, 2014.

573 views • 35 slides

How to get published in Asian EFL Journal JALT Niigata June 23 rd , 2013

How to get published in Asian EFL Journal JALT Niigata June 23 rd , 2013. John Adamson UNP. Overview. Asian EFL Journal (est. 2002): partial OA The Linguistics Journal (est. 2005): OA Asian ESP Journal (est. 2005): OA English as an International Language Journal (est. 2007):OA

288 views • 13 slides

R Bagchi et al. Nature 000 , 1-4 (2014) doi:10.1038/nature12911

Recruitment across the seed-to-seedling transition showed NDD in the control, but spraying with the fungicide Amistar removed this NDD. R Bagchi et al. Nature 000 , 1-4 (2014) doi:10.1038/nature12911.

161 views • 1 slides

Challenges Representing Phenotype in Pharmacogenomics

Challenges Representing Phenotype in Pharmacogenomics. Tina Hernandez-Boussard PharmGKB www.pharmGkB.org. Pharmacogenomics. Understanding how genetic variation leads to variation in responses to drugs A promise from the Genome Project Personalized Medicine

349 views • 18 slides

AYY Tan et al. Nature 000 , 1-4 (2014) doi:10.1038/nature13159

Occasional large spontaneous fluctuations in V m during fixation. AYY Tan et al. Nature 000 , 1-4 (2014) doi:10.1038/nature13159.

113 views • 1 slides

V Hovestadt et al. Nature 000 , 1-5 (2014) doi:10.1038/nature13268

Megabase-scale silenced domains and smaller DMVs are associated with distinct histone marks and positive correlation with expression. V Hovestadt et al. Nature 000 , 1-5 (2014) doi:10.1038/nature13268.

119 views • 1 slides

A Laganowsky et al. Nature 510 , 172-175 (2014) doi:10.1038/nature13419

AqpZ is indiscriminately stabilized by lipids with the exception of cardiolipin, a lipid that stabilizes the channel significantly and modulates its function. A Laganowsky et al. Nature 510 , 172-175 (2014) doi:10.1038/nature13419.

95 views • 1 slides

S Schleich et al. Nature 000 , 1-5 (2014) doi:10.1038/nature13401

DENR promotes cell proliferation and boosts protein synthesis in proliferating but not quiescent cells. S Schleich et al. Nature 000 , 1-5 (2014) doi:10.1038/nature13401.

112 views • 1 slides

VM Sandler et al. Nature 000 , 1-7 (2014) doi:10.1038/nature13547

Reprogramming of HUVECs and hES-ECs into haematopoietic cells by FGRS transcription-factor transduction and vascular induction. VM Sandler et al. Nature 000 , 1-7 (2014) doi:10.1038/nature13547.

149 views • 1 slides

Z Wu et al. Nature 509 , 325-330 (2014) doi:10.1038/nature13307

Optogenetic activation of MPOA Ga l + neurons in males suppresses attack and promotes pup grooming. Z Wu et al. Nature 509 , 325-330 (2014) doi:10.1038/nature13307.

144 views • 1 slides

SJ Lee et al. Nature 000 , 1-5 (2013) doi:10.1038/nature11880

Conformational changes near the diiron centre and pore residues in MMOH after MMOB binding. SJ Lee et al. Nature 000 , 1-5 (2013) doi:10.1038/nature11880.

124 views • 1 slides

K Choudhuri et al. Nature 000 , 1-6 (2014) doi:10.1038/nature12951

TCR-enriched microvesicles are post-signalling extracellular products of T-cell activation that retain pMHC-binding competence. K Choudhuri et al. Nature 000 , 1-6 (2014) doi:10.1038/nature12951.

117 views • 1 slides

S Li et al. Nature 000 , 1-5 (2013) doi:10.1038/nature12436

Disrupting several death receptor pathways by NleB GlcNAc transferase activity that is required for bacterial colonization in vivo. S Li et al. Nature 000 , 1-5 (2013) doi:10.1038/nature12436.

172 views • 1 slides

H Wen et al. Nature 000 , 1-6 (2014) doi:10.1038/nature13045

Molecular basis for H3.3K36me3 recognition by ZMYND11 bromo–PWWP domains. H Wen et al. Nature 000 , 1-6 (2014) doi:10.1038/nature13045.

184 views • 1 slides

Mucosal Immunology (2014) 7 , <#/>842<#/><epn>856<#/>; doi:10.1038/mi.2013.101

Figure 5. Mucosal Immunology (2014) 7 , <#/>842<#/><epn>856<#/>; doi:10.1038/mi.2013.101.

174 views • 1 slides

More Related

Unleashing the Potential of Pharmacogenomics in Precision Medicine

Unleashing the Potential of Pharmacogenomics in Precision Medicine

Presentation Transcript

Cancer Pharmacogenomics From Bench to Bedside

V8 Pharmacogenomics

Fuentes QE et al . Platelets, 2013;24:255-62.

Journal August 19, 2013

Chapter 7: Pharmacogenomics

World History Journal

How to get published in Asian EFL Journal JALT Niigata June 23 rd , 2013

R Bagchi et al. Nature 000 , 1-4 (2014) doi:10.1038/nature12911

Challenges Representing Phenotype in Pharmacogenomics

AYY Tan et al. Nature 000 , 1-4 (2014) doi:10.1038/nature13159

V Hovestadt et al. Nature 000 , 1-5 (2014) doi:10.1038/nature13268

A Laganowsky et al. Nature 510 , 172-175 (2014) doi:10.1038/nature13419

S Schleich et al. Nature 000 , 1-5 (2014) doi:10.1038/nature13401

VM Sandler et al. Nature 000 , 1-7 (2014) doi:10.1038/nature13547

Z Wu et al. Nature 509 , 325-330 (2014) doi:10.1038/nature13307

SJ Lee et al. Nature 000 , 1-5 (2013) doi:10.1038/nature11880

K Choudhuri et al. Nature 000 , 1-6 (2014) doi:10.1038/nature12951

S Li et al. Nature 000 , 1-5 (2013) doi:10.1038/nature12436

H Wen et al. Nature 000 , 1-6 (2014) doi:10.1038/nature13045

Mucosal Immunology (2014) 7 , &lt;#/&gt;842&lt;#/&gt;&lt;epn&gt;856&lt;#/&gt;; doi:10.1038/mi.2013.101

Mucosal Immunology (2014) 7 , <#/>842<#/><epn>856<#/>; doi:10.1038/mi.2013.101